Luke S. Gill

Examining the unique standards and related challenges when assessing the safety and efficacy of cancer immunotherapy candidates.

Cancer immunotherapies require different standards for evaluating their safety and effectiveness. Understanding these standards-and the other major challenges of immuno-oncology studies-is critical to drug development success.